Priorities for Public–Private Cooperation to Mitigate Risk and Impact of Global Catastrophic Biological Risks

  • Ryan MorhardEmail author
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 424)


By definition, Global Catastrophic Biological Risks (GCBRs) are “beyond the collective capability of national and international governments and the private sector to control”. Implicit in this definition is that no single country, sector, or entity can effectively mitigate risk and impact of GCBRs and that doing so requires public-private cooperation. This short commentary offers five trends suggesting that conditions for cooperation are favorable, along with three gaps to be addressed, and five high-level recommendations to strengthen public-private cooperation to mitigate risk and impact of GCBRs.


  1. Fan VY, Jamison DT, Summers LH (2016) The inclusive cost of pandemic influenza risk (No. w22137). National Bureau of Economic ResearchGoogle Scholar
  2. Fidler DP (1998) Microbialpolitik: infectious diseases and international relations. Am Univ Int Law Rev 14:1Google Scholar
  3. Huber C, Finelli L, Stevens W (2018) The economic and social burden of the 2014 Ebola outbreak in West Africa. J Infect Dis 218 (suppl_5):S698–S704Google Scholar
  4. Jonas OB (2013) Pandemic risk. World Bank, Washington, DC. © World Bank. License: CC BY 3.0 IGO
  5. Oh MD, Park WB, Park SW, Choe PG, Bang JH, Song KH, Kim ES, Kim HB, Kim NJ (2018) Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea. Korean J Intern Med 33(2):233CrossRefGoogle Scholar
  6. Sands P, El Turabi A, Saynisch PA, Dzau VJ (2016) Assessment of economic vulnerability to infectious disease crises. Lancet 388(10058):2443–2448CrossRefGoogle Scholar
  7. Schoch-Spana M, Cicero A, Adalja A, Gronvall G, Kirk Sell T, Meyer D, Nuzzo JB, Ravi S, Shearer MP, Toner E, Watson C (2017) Global catastrophic biological risks: toward a working definition. Health Secur 15(4):323–328CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Global Health and Healthcare Industries, World Economic ForumColognySwitzerland

Personalised recommendations